Close Menu

NEW YORK — The US Food and Drug Administration on Friday granted Emergency Use Authorization (EUA) for three PCR-based tests for SARS-CoV-2 including ones developed by Orig3n, Specialty Diagnostic Laboratories (SDI), and the University of North Carolina (UNC) Medical Center.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.